Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 12/01/21
End: 11/30/27
Due: 11/30/28
Phase: N/A
Priority: Normal
Start: 07/01/18
End: 06/30/23
Due: 06/30/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis | NCT03316651 | Dai Huaping | user2@example.com | None | 2016-08-31 | 2020-12-31 | 2021-12-31 | - | - | 2025-07-14 |
| Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China | NCT06655090 | Dai Huaping | user2@example.com | None | 2021-12-01 | 2027-11-30 | 2028-11-30 | - | - | 2025-07-14 |
| Idiopathic Pulmonary Fibrosis Registry China Study | NCT03666234 | Dai Huaping | user2@example.com | None | 2018-07-01 | 2023-06-30 | 2024-06-30 | - | - | 2025-07-14 |